Titan Media talks with Xu Qing from Yuanhe Chencun: The local fund-of-funds, a "lone hero," prefers to seek out "dark horse" GPs.

2022-08-26

Titan Media interviews Xu Qing, Managing Partner at Yuanhe Chencun, to explore how the firm has managed to secure continuous fundraising throughout its journey, navigate market cycles, and refine its investment strategy amid industry volatility. Additionally, the conversation delves into Xu’s perspectives on the future trajectory of China’s venture capital landscape.

Xu Qing: Equity Investment and Fund-of-Funds Management in the New Environment

2022-08-22

On July 30–31, 2022, at the 2022 China Fund of Funds 50 Forum, Ms. Qing Xu, Managing Partner of Yuanhe Chencun, delivered a speech titled "Private Equity Investment and Fund-of-Funds Management in the New Environment."

United Imaging Healthcare Successfully Launches IPO, Marking the Largest Listing on the STAR Market This Year | Chenkun Family

2022-08-22

On August 22, United Imaging Healthcare, the portfolio company invested in by Yuanhe Chencun-managed fund-of-funds through its sub-fund Source Capital, officially listed on the STAR Market of the Shanghai Stock Exchange, with stock code: 688271.

Huicheng Shares Successfully Lists on the STAR Market | Chenkun Family

2022-08-18

On August 18, "Huicheng Shares," an investee company of Kunqiao Capital—a sub-fund backed by the mother fund managed by Yuanhe Chenchun Capital—officially listed on the STAR Market of the Shanghai Stock Exchange, with stock code: 688403.

Qu Shui Technology Successfully Lists on the ChiNext Board | Chenkun Family

2022-08-12

On August 12, "Qu Shui Technology," a portfolio company invested in by the sub-fund managed by Yuanhe Chencun's mother fund—Shunwei Capital—officially listed on the ChiNext Board of the Shenzhen Stock Exchange, with stock code: 301336.

Super Antibiotic Pioneer—Alliance Pharma Successfully Lists on the STAR Market | Chenkun Family

2022-08-05

On August 5, "Mengke Pharmaceutical," a portfolio company backed by sub-funds invested in through the mother fund managed by Yuanhe Chenkun—specifically Junlian Capital and Detong Capital—officially listed on the STAR Market of the Shanghai Stock Exchange, with stock code: 688373.